Methyl 2-Oxoindoline-6-Carboxylate CAS 14192-26-8 Purity>99.0% (HPLC) Nintedanib Esylate Intermediate Factory

Kufotokozera Kwachidule:

Dzina la Mankhwala: Methyl 2-Oxoindoline-6-Carboxylate

CAS: 14192-26-8

Kuyera: > 99.0% (HPLC)

Maonekedwe: Ufa Wachikasu Wopepuka mpaka Wabulauni

Wapakati wa Nintedanib Esylate (CAS: 656247-18-6) pochiza khansa ya m'mapapo yopanda maselo ang'onoang'ono & idiopathic pulmonary fibrosis (IPF)

Ubwino Wapamwamba, Kupanga Zamalonda

E-Mail: alvin@ruifuchem.com

Titumizireni imelo

Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Shanghai Ruifu Chemical Co., Ltd. ndiwopanga komanso wogulitsa Methyl 2-Oxoindoline-6-Carboxylate (CAS: 14192-26-8) yokhala ndiukadaulo wapamwamba kwambiri, wopanga malonda.

Chemical Properties:

Dzina la Chemical	Methyl 2-Oxoindoline-6-Carboxylate
Mawu ofanana ndi mawu	2-Oxoindoline-6-Carboxylic Acid Methyl Ester;Methyl Oxindole-6-Carboxylate
Nambala ya CAS	14192-26-8
Nambala ya CAT	Chithunzi cha RF-PI1524
Stock Status	Mu Stock, Kupanga Kukula Mpaka Matani
Molecular Formula	C10H9NO3
Kulemera kwa Maselo	191.19
Melting Point	184.0 ~ 190.0 ℃
Mtundu	Ruifu Chemical

Zofotokozera:

Kanthu	Zofotokozera
Maonekedwe	Ufa Wachikasu Wopepuka mpaka Wabulauni
1 H NMR Spectrum	Zogwirizana ndi Kapangidwe
Kuyera / Kusanthula Njira	>99.0% (HPLC)
Kutaya pa Kuyanika	<1.00%
Zonse Zonyansa	<1.00%
Test Standard	Enterprise Standard
Kugwiritsa ntchito	Pakati pa Nintendodanib Esylate (CAS: 656247-18-6)

Methyl 2-Oxoindoline-6-Carboxylate (CAS: 14192-26-8) Njira Yopanga

Phukusi & Kusunga:

Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi zofunika kasitomala.

Mkhalidwe Wosungira:Sungani muzitsulo zosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi.

Ubwino:

FAQ:

Ntchito:

Methyl 2-Oxoindoline-6-Carboxylate (CAS: 14192-26-8) ndi yapakatikati yomwe imagwiritsidwa ntchito pokonzekera Nintedanib Esylate (CAS: 656247-18-6).Nintedanib Esylate ndi amphamvu, oral triple angiokinase inhibitor yopangidwa ndi Boehringer Ingelheim yomwe imayang'ana njira za proangiogenic ndi pro-fibrotic zomwe zimalumikizidwa ndi vascular endothelial growth factor receptor, fibroblast growth factor receptor ndi plateletderived growth factor receptor mabanja, komanso Src ndi Flt-3. kinase.Nintedanib Esylate adavomerezedwa kuti azichiza matenda a idiopathic pulmonary fibrosis (IPF), momwe mapapu amakhala amabala pang'onopang'ono pakapita nthawi, ndi US FDA mu Okutobala 2014 ndi EMA mu Januware 2015. FDA idapereka nintedanib esylate mwachangu. , kuunikanso koyambirira, malonda a ana amasiye, ndi mayina opambana.Idavomerezedwanso ndi EMA mu Novembala 2014 pochiza khansa ya m'mapapo yosakhala yaying'ono kuphatikiza ndi docetaxel pambuyo pamankhwala oyamba a chemotherapy.